COL20A1
geneOn this page
Also known as KIAA1510
Summary
COL20A1 (collagen type XX alpha 1 chain, HGNC:14670) is a protein-coding gene on chromosome 20q13.33, encoding Collagen alpha-1(XX) chain (Q9P218). Probable collagen protein.
Predicted to be located in collagen-containing extracellular matrix; endoplasmic reticulum lumen; and extracellular region. Predicted to be part of collagen trimer.
Source: NCBI Gene 57642 — RefSeq curated summary.
At a glance
- Gene–disease (curated): hereditary palmoplantar keratoderma (Limited, GenCC)
- Clinical variants (ClinVar): 301 total — 1 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_020882
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14670 |
| Approved symbol | COL20A1 |
| Name | collagen type XX alpha 1 chain |
| Location | 20q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1510 |
| Ensembl gene | ENSG00000101203 |
| Ensembl biotype | protein_coding |
| OMIM | 619390 |
| Entrez | 57642 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000358894, ENST00000415763, ENST00000422202, ENST00000455906, ENST00000471582, ENST00000479501, ENST00000494913, ENST00000496810, ENST00000894509, ENST00000938907
RefSeq mRNA: 1 — MANE Select: NM_020882
NM_020882
CCDS: CCDS46628
Canonical transcript exons
ENST00000358894 — 36 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000663393 | 63312420 | 63312549 |
| ENSE00000663399 | 63319058 | 63319200 |
| ENSE00000663400 | 63319487 | 63319596 |
| ENSE00000856569 | 63309758 | 63309915 |
| ENSE00000856570 | 63315404 | 63315439 |
| ENSE00001410478 | 63293186 | 63293275 |
| ENSE00001563363 | 63328079 | 63328127 |
| ENSE00003470528 | 63325441 | 63325494 |
| ENSE00003474099 | 63326752 | 63326823 |
| ENSE00003474637 | 63297910 | 63298020 |
| ENSE00003480561 | 63320039 | 63320197 |
| ENSE00003487082 | 63311394 | 63311539 |
| ENSE00003488141 | 63321013 | 63321099 |
| ENSE00003495329 | 63313743 | 63313891 |
| ENSE00003495444 | 63307971 | 63308090 |
| ENSE00003505924 | 63310381 | 63310510 |
| ENSE00003521148 | 63322058 | 63322111 |
| ENSE00003544146 | 63295098 | 63295189 |
| ENSE00003552700 | 63316553 | 63316691 |
| ENSE00003555782 | 63305417 | 63305560 |
| ENSE00003564929 | 63307490 | 63307648 |
| ENSE00003568716 | 63327952 | 63327987 |
| ENSE00003574827 | 63314072 | 63314201 |
| ENSE00003577918 | 63312792 | 63312934 |
| ENSE00003588427 | 63311916 | 63312055 |
| ENSE00003594118 | 63309333 | 63309497 |
| ENSE00003595032 | 63311625 | 63311748 |
| ENSE00003602530 | 63305881 | 63306039 |
| ENSE00003602678 | 63326096 | 63326149 |
| ENSE00003622430 | 63329585 | 63329661 |
| ENSE00003634044 | 63308542 | 63308706 |
| ENSE00003678876 | 63325668 | 63325721 |
| ENSE00003690224 | 63320291 | 63320368 |
| ENSE00003694095 | 63313117 | 63313249 |
| ENSE00003786935 | 63328331 | 63328498 |
| ENSE00003936648 | 63330720 | 63334806 |
Expression profiles
Bgee: expression breadth ubiquitous, 133 present calls, max score 87.70.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4232 / max 48.4954, expressed in 107 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 185806 | 0.4232 | 107 |
Top tissues by expression
230 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 87.70 | gold quality |
| left testis | UBERON:0004533 | 86.85 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.41 | gold quality |
| right frontal lobe | UBERON:0002810 | 85.57 | gold quality |
| amygdala | UBERON:0001876 | 84.91 | gold quality |
| pancreatic ductal cell | CL:0002079 | 83.79 | silver quality |
| testis | UBERON:0000473 | 83.59 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.75 | gold quality |
| endothelial cell | CL:0000115 | 82.05 | silver quality |
| nucleus accumbens | UBERON:0001882 | 80.45 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 80.33 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 79.75 | gold quality |
| substantia nigra | UBERON:0002038 | 79.01 | gold quality |
| tibialis anterior | UBERON:0001385 | 78.64 | silver quality |
| spinal cord | UBERON:0002240 | 78.50 | gold quality |
| neocortex | UBERON:0001950 | 78.17 | gold quality |
| putamen | UBERON:0001874 | 78.09 | gold quality |
| temporal lobe | UBERON:0001871 | 77.98 | gold quality |
| Ammon’s horn | UBERON:0001954 | 77.88 | gold quality |
| cerebral cortex | UBERON:0000956 | 77.74 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 77.56 | gold quality |
| midbrain | UBERON:0001891 | 77.50 | gold quality |
| frontal cortex | UBERON:0001870 | 77.48 | gold quality |
| hypothalamus | UBERON:0001898 | 77.00 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.84 | gold quality |
| buccal mucosa cell | CL:0002336 | 76.81 | gold quality |
| forebrain | UBERON:0001890 | 76.65 | gold quality |
| brain | UBERON:0000955 | 76.28 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.68 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.60 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-93593 | yes | 5.58 |
| E-ANND-3 | yes | 3.76 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting COL20A1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-548V | 99.29 | 69.47 | 1157 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
| HSA-MIR-4539 | 98.78 | 67.18 | 888 |
| HSA-MIR-193B-5P | 97.91 | 65.88 | 837 |
Literature-anchored findings (GeneRIF, showing 2)
- Our study proposes COL20A1 gene as another potential candidate gene for striate palmoplantar keratoderma (PPKS)which expand the spectrum of collagen proteins in the pathogenicity of Palmoplantar keratoderma. (PMID:29934816)
- Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors. (PMID:35456962)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Col20a1 | ENSMUSG00000016356 |
Paralogs (37): COL9A2 (ENSG00000049089), COL23A1 (ENSG00000050767), COL11A1 (ENSG00000060718), COL17A1 (ENSG00000065618), COL5A3 (ENSG00000080573), COL4A4 (ENSG00000081052), COL16A1 (ENSG00000084636), COL9A3 (ENSG00000092758), COL1A1 (ENSG00000108821), COL9A1 (ENSG00000112280), COL7A1 (ENSG00000114270), COL21A1 (ENSG00000124749), COL5A1 (ENSG00000130635), COL4A2 (ENSG00000134871), COL2A1 (ENSG00000139219), COL6A1 (ENSG00000142156), COL6A2 (ENSG00000142173), EDA (ENSG00000158813), COL26A1 (ENSG00000160963), COL1A2 (ENSG00000164692), COL3A1 (ENSG00000168542), COL4A3 (ENSG00000169031), COL22A1 (ENSG00000169436), COL24A1 (ENSG00000171502), COL18A1 (ENSG00000182871), EMID1 (ENSG00000186998), COL4A1 (ENSG00000187498), COL4A5 (ENSG00000188153), COL25A1 (ENSG00000188517), COL27A1 (ENSG00000196739), COL13A1 (ENSG00000197467), COL4A6 (ENSG00000197565), COL11A2 (ENSG00000204248), COL5A2 (ENSG00000204262), COL15A1 (ENSG00000204291), COLQ (ENSG00000206561), COL28A1 (ENSG00000215018)
Protein
Protein identifiers
Collagen alpha-1(XX) chain — Q9P218 (reviewed: Q9P218)
All UniProt accessions (3): Q9P218, B7ZBI4, B7ZBI5
UniProt curated annotations — full annotation on UniProt →
Function. Probable collagen protein.
Subcellular location. Secreted. Extracellular space.
Tissue specificity. High expression in heart, lung, liver, skeletal muscle, kidney, pancreas, spleen, testis, ovary, subthalamic nucleus and fetal liver. Weak expression in other tissues tested.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9P218-1 | 1 | yes |
| Q9P218-2 | 2 | |
| Q9P218-3 | 3 |
RefSeq proteins (1): NP_065933* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002035 | VWF_A | Domain |
| IPR003961 | FN3_dom | Domain |
| IPR008160 | Collagen | Repeat |
| IPR013320 | ConA-like_dom_sf | Homologous_superfamily |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036116 | FN3_sf | Homologous_superfamily |
| IPR036465 | vWFA_dom_sf | Homologous_superfamily |
| IPR048287 | TSPN-like_N | Domain |
| IPR050991 | ECM_Regulatory_Proteins | Family |
Pfam: PF00041, PF00092, PF01391
UniProt features (57 total): strand 27, domain 10, sequence conflict 5, compositionally biased region 4, region of interest 3, splice variant 3, signal peptide 1, chain 1, glycosylation site 1, sequence variant 1, turn 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 5KF4 | X-RAY DIFFRACTION | 2.5 |
| 2DKM | SOLUTION NMR | |
| 2EE3 | SOLUTION NMR | |
| 2EKJ | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P218-F1 | 73.88 | 0.24 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 607
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1650814 | Collagen biosynthesis and modifying enzymes |
| R-HSA-8948216 | Collagen chain trimerization |
MSigDB gene sets: 59 (showing top):
GOCC_COLLAGEN_TRIMER, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, DARWICHE_PAPILLOMA_PROGRESSION_RISK, COATES_MACROPHAGE_M1_VS_M2_DN, MODULE_48, MODULE_95, GOCC_ENDOPLASMIC_RETICULUM_LUMEN, NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON, MARTENS_TRETINOIN_RESPONSE_UP, CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, MODULE_163
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (4): extracellular region (GO:0005576), collagen trimer (GO:0005581), endoplasmic reticulum lumen (GO:0005788), extracellular matrix (GO:0031012)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Collagen formation | 1 |
| Collagen biosynthesis and modifying enzymes | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
| protein-containing complex | 1 |
| endoplasmic reticulum | 1 |
| intracellular organelle lumen | 1 |
| external encapsulating structure | 1 |
Protein interactions and networks
STRING
930 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COL20A1 | CNIH1 | O95406 | 495 |
| COL20A1 | CNIH3 | Q8TBE1 | 490 |
| COL20A1 | ARSJ | Q5FYB0 | 448 |
| COL20A1 | PALMD | Q9NP74 | 439 |
| COL20A1 | RIC3 | Q7Z5B4 | 429 |
| COL20A1 | IFT38 | Q96AJ1 | 427 |
| COL20A1 | KLHL31 | Q9H511 | 427 |
| COL20A1 | SEC16B | Q96JE7 | 423 |
| COL20A1 | ACAD10 | Q6JQN1 | 418 |
| COL20A1 | TDRD7 | Q8NHU6 | 405 |
| COL20A1 | UBE2H | P37286 | 400 |
| COL20A1 | MKNK1 | Q9BUB5 | 385 |
| COL20A1 | AUTS2 | Q8WXX7 | 383 |
| COL20A1 | COL26A1 | Q96A83 | 382 |
| COL20A1 | ADAMTS14 | Q8WXS8 | 350 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPC3 | CLGN | psi-mi:“MI:0914”(association) | 0.530 |
| ATP5MC3 | ATP5F1B | psi-mi:“MI:0914”(association) | 0.530 |
| JPT1 | COL20A1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| UBE2B | COL20A1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| USP47 | COL20A1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| COL20A1 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.370 |
| ECE1 | COL20A1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TEX11 | COL20A1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| COL20A1 | MANBA | psi-mi:“MI:0914”(association) | 0.350 |
| NUDT16 | BCKDK | psi-mi:“MI:0914”(association) | 0.350 |
| COL20A1 | TSC2 | psi-mi:“MI:0914”(association) | 0.350 |
| CPLX3 | ATE1 | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (31): COL20A1 (Two-hybrid), COL20A1 (Two-hybrid), FAM9B (Two-hybrid), COL20A1 (Two-hybrid), GGACT (Affinity Capture-MS), TSC2 (Affinity Capture-MS), COL14A1 (Affinity Capture-MS), COL20A1 (Affinity Capture-MS), MEIS1 (Affinity Capture-MS), CDKN2C (Affinity Capture-MS), PBX2 (Affinity Capture-MS), GLS (Affinity Capture-MS), PPP2CA (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), COL20A1 (Affinity Capture-MS)
ESM2 similar proteins: A0A140LHF2, A0JPB1, A2AJ76, A7LCJ3, A8E0Y8, E7FF10, O00241, O60500, P01874, P03988, P04221, P0DOX2, P0DOX3, P0DOX4, P0DOX6, P0DP72, P32507, P35590, P43121, P50895, Q06805, Q06806, Q148M6, Q15109, Q5TFQ8, Q5U5A3, Q5XI43, Q62230, Q62786, Q8HW98, Q8NDA2, Q8R2Y2, Q92154, Q923P0, Q93033, Q95KI3, Q96MS0, Q9BRK3, Q9BZZ2, Q9DBV4
Diamond homologs: A0A1D5NSM8, A0JNA2, A2AVA0, A2AX52, D3YXF5, O02839, O19063, O35764, O43405, O70340, O76536, O89029, O95502, O96530, P02741, P02743, P06205, P06206, P06207, P06681, P07202, P07629, P08607, P09871, P0C6B8, P10643, P12246, P13944, P14151, P14847, P15697, P18337, P23680, P32018, P47970, P47971, P47972, P48199, P49254, P49262
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
301 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 1 |
| Uncertain significance | 259 |
| Likely benign | 28 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 564629 | GRCh37/hg19 20q13.33(chr20:61815143-62318983)x1 | Pathogenic |
| 1326328 | GRCh37/hg19 20q13.33(chr20:61944468-62104030) | Likely pathogenic |
SpliceAI
7330 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:63294752:G:GT | donor_gain | 1.0000 |
| 20:63297908:A:AG | acceptor_gain | 1.0000 |
| 20:63297909:G:GG | acceptor_gain | 1.0000 |
| 20:63297909:GCA:G | acceptor_gain | 1.0000 |
| 20:63297909:GCAA:G | acceptor_gain | 1.0000 |
| 20:63305553:GTTT:G | donor_gain | 1.0000 |
| 20:63305557:GTGA:G | donor_gain | 1.0000 |
| 20:63305559:GA:G | donor_gain | 1.0000 |
| 20:63305561:G:GG | donor_gain | 1.0000 |
| 20:63305879:A:AG | acceptor_gain | 1.0000 |
| 20:63305880:G:GC | acceptor_gain | 1.0000 |
| 20:63305880:GTT:G | acceptor_gain | 1.0000 |
| 20:63305880:GTTGA:G | acceptor_gain | 1.0000 |
| 20:63305988:GCTTC:G | donor_gain | 1.0000 |
| 20:63306263:G:GT | donor_gain | 1.0000 |
| 20:63306311:G:GT | donor_gain | 1.0000 |
| 20:63306359:G:GT | donor_gain | 1.0000 |
| 20:63307645:GTAG:G | donor_gain | 1.0000 |
| 20:63309330:CA:C | acceptor_loss | 1.0000 |
| 20:63309331:AGGTG:A | acceptor_loss | 1.0000 |
| 20:63309332:G:T | acceptor_loss | 1.0000 |
| 20:63311392:A:AG | acceptor_gain | 1.0000 |
| 20:63311393:G:GA | acceptor_gain | 1.0000 |
| 20:63311537:GAG:G | donor_gain | 1.0000 |
| 20:63311744:GACCC:G | donor_gain | 1.0000 |
| 20:63311749:G:GG | donor_gain | 1.0000 |
| 20:63312922:G:T | donor_gain | 1.0000 |
| 20:63313207:G:T | donor_gain | 1.0000 |
| 20:63316551:AG:A | acceptor_gain | 1.0000 |
| 20:63316552:GG:G | acceptor_gain | 1.0000 |
AlphaMissense
8163 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:63313816:G:C | W761C | 0.983 |
| 20:63313816:G:T | W761C | 0.983 |
| 20:63313814:T:A | W761R | 0.980 |
| 20:63313814:T:C | W761R | 0.980 |
| 20:63307594:T:C | F201L | 0.977 |
| 20:63307596:C:A | F201L | 0.977 |
| 20:63307596:C:G | F201L | 0.977 |
| 20:63312487:T:A | V624D | 0.976 |
| 20:63307538:T:C | F182S | 0.975 |
| 20:63297965:G:C | W46C | 0.974 |
| 20:63297965:G:T | W46C | 0.974 |
| 20:63305554:T:C | F111L | 0.974 |
| 20:63305556:T:A | F111L | 0.974 |
| 20:63305556:T:G | F111L | 0.974 |
| 20:63307547:A:T | D185V | 0.973 |
| 20:63311461:G:C | W487C | 0.973 |
| 20:63311461:G:T | W487C | 0.973 |
| 20:63307595:T:C | F201S | 0.972 |
| 20:63307558:A:C | S189R | 0.969 |
| 20:63307560:C:A | S189R | 0.969 |
| 20:63307560:C:G | S189R | 0.969 |
| 20:63309841:T:A | W397R | 0.969 |
| 20:63309841:T:C | W397R | 0.969 |
| 20:63311459:T:A | W487R | 0.969 |
| 20:63311459:T:C | W487R | 0.969 |
| 20:63308008:G:C | W231C | 0.966 |
| 20:63308008:G:T | W231C | 0.966 |
| 20:63314145:T:A | V811D | 0.964 |
| 20:63309843:G:C | W397C | 0.963 |
| 20:63309843:G:T | W397C | 0.963 |
dbSNP variants (sampled 300 via entrez): RS1000003062 (20:63299787 T>C), RS1000019703 (20:63309036 G>A), RS1000022222 (20:63293779 CCT>C), RS1000073974 (20:63305109 G>A), RS1000196661 (20:63312883 G>A,C), RS1000360006 (20:63321420 C>A,G,T), RS1000366283 (20:63298905 G>A), RS1000412398 (20:63321111 G>A), RS1000542168 (20:63312223 G>A), RS1000735505 (20:63317076 G>A,T), RS1000785414 (20:63312258 T>A), RS1000836985 (20:63320470 G>A), RS1000993305 (20:63294437 C>T), RS1001001067 (20:63308283 G>A), RS1001003355 (20:63302379 G>T)
Disease associations
OMIM: gene MIM:619390 | disease phenotypes: MIM:148700, MIM:121200, MIM:613720
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| hereditary palmoplantar keratoderma | Limited | Autosomal dominant |
Mondo (4): palmoplantar keratoderma i, striate, focal, or diffuse (MONDO:0007859), seizures, benign familial neonatal, 1 (MONDO:0007365), developmental and epileptic encephalopathy, 7 (MONDO:0013387), hereditary palmoplantar keratoderma (MONDO:0019272)
Orphanet (4): Diffuse palmoplantar keratoderma with painful fissures (Orphanet:369999), Focal palmoplantar keratoderma with joint keratoses (Orphanet:370002), Self-limited neonatal epilepsy (Orphanet:1949), KCNQ2-related developmental and epileptic encephalopathy (Orphanet:439218)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (2)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C567743 | Epilepsy, Benign Neonatal, 1, And-Or Myokymia (supp.) | |
| C536162 | Keratosis palmoplantaris striata 1 (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| Cisplatin | affects cotreatment, increases expression, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| calfactant | increases expression, affects cotreatment | 1 |
| bisphenol S | decreases methylation | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Copper | affects cotreatment, increases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Paclitaxel | affects cotreatment, increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Nanotubes, Carbon | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: hereditary palmoplantar keratoderma
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): developmental and epileptic encephalopathy, 7, hereditary palmoplantar keratoderma, palmoplantar keratoderma i, striate, focal, or diffuse, seizures, benign familial neonatal, 1